Rachdaoui N. Insulin: the friend and the foe in the development of type 2 diabetes mellitus. Int J Mol Sci. 2020;21(5):1770.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piché M-E, Tchernof A, Després J-P. Obesity phenotypes, diabetes, and cardiovascular diseases. Circ Res. 2020;126(11):1477–500.

Article  PubMed  Google Scholar 

Andevari AN, Moein S, Qujeq D, Moazezi Z, Tilaki KH. The effect of atorvastatin on the concentrations of methylglyoxal, glyoxalase 1, and aldo–keto reductase family 1 member B10 in patients with type 2 diabetes mellitus and prediabetes. Int J Diabetes Dev Ctries. 2024;44(2):400–8.

Article  CAS  Google Scholar 

Climent E, Benaiges D, Pedro-Botet J. Hydrophilic or lipophilic statins? Front Cardiovasc Med. 2021;8:687585.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Balasubramanian R, Maideen NM. HMG-CoA reductase inhibitors (statins) and their drug interactions involving CYP enzymes, P-glycoprotein and OATP transporters-an overview. Curr Drug Metab. 2021;22(5):328–41.

CAS  PubMed  Google Scholar 

White CM. A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin. J Clin Pharmacol. 2002;42(9):963–70.

Article  CAS  PubMed  Google Scholar 

Febbraro F, Andersen HHB, Kitt MM, Willnow TE. Spatially and temporally distinct patterns of expression for VPS10P domain receptors in human cerebral organoids. Front Cell Dev Biol. 2023;11:1229584.

Article  PubMed  PubMed Central  Google Scholar 

Andevari AN, Moein S, Qujeq D, Moazezi Z, Tilaki KH. Effects of atrovastatin on concentrations of 3-hydroxy-3-methylglutaryl-coenzyme A-reductase (HMG-CoA-R), proprotein convertase subtilisin/kexin type 9 (PCSK9) and sortilin in patients with type 2 diabetes mellitus and pre-diabetics. J Nephropathol. 2020;10(1):e05-e.

Article  Google Scholar 

Li J, Matye DJ, Li T. Insulin resistance induces posttranslational hepatic sortilin 1 degradation in mice. J Biol Chem. 2015;290(18):11526–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Namitokov A. Sortilin and its potential role in cardiovascular pathology. Egypt Heart J. 2024;76(1):78.

Article  PubMed  PubMed Central  Google Scholar 

Taghibiglou C, Bradley CA, Gaertner T, Li Y, Wang Y, Wang YT. Mechanisms involved in cholesterol-induced neuronal insulin resistance. Neuropharmacology. 2009;57(3):268–76.

Article  CAS  PubMed  Google Scholar 

Xu W, Zhang D, Ma Y, Gaspar RC, Kahn M, Nasiri A, et al. Ceramide synthesis inhibitors prevent lipid-induced insulin resistance through the DAG-PKCε-insulin receptorT1150 phosphorylation pathway. Cell Rep. 2024;43(10):114746 https://doi.org/10.1016/j.celrep.2024.114746.

Article  PubMed  PubMed Central  Google Scholar 

Shiri H, Fallah H, Abolhassani M, Fooladi S, Ramezani Karim Z, Danesh B, et al. Relationship between types and levels of free fatty acids, peripheral insulin resistance, and oxidative stress in T2DM: a case-control study. PLoS ONE. 2024;19(8):e0306977.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhong L-y, Cayabyab FS, Tang C-k, Zheng X-l, Peng T-h, Lv Y-c. Sortilin: a novel regulator in lipid metabolism and atherogenesis. Clin Chim Acta. 2016;460:11–7.

Article  CAS  PubMed  Google Scholar 

Teslovich TM, Musunuru K, Smith AV, Edmondson AC, Stylianou IM, Koseki M, et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010;466(7307):707–13.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hagita S, Rogers MA, Pham T, Wen JR, Mlynarchik AK, Aikawa M, et al. Transcriptional control of intestinal cholesterol absorption, adipose energy expenditure and lipid handling by Sortilin. Sci Rep. 2018;8(1):9006.

Article  PubMed  PubMed Central  Google Scholar 

Tveten K, Strøm TB, Cameron J, Berge KE, Leren TP. Mutations in the SORT1 gene are unlikely to cause autosomal dominant hypercholesterolemia. Atherosclerosis. 2012;225(2):370–5.

Article  CAS  PubMed  Google Scholar 

Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature. 2010;466(7307):714–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Conlon DM, Schneider CV, Ko Y-A, Rodrigues A, Guo K, Hand NJ, et al. Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions. J Clin Invest. 2022;132(6):e443334.  https://doi.org/10.1172/JCI144334.

Article  PubMed  PubMed Central  Google Scholar 

Sparks CE, Sparks RP, Sparks JD. The enigmatic role of sortilin in lipoprotein metabolism. Curr Opin Lipidol. 2015;26(6):598–600.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andevari AN, Moein S, Qujeq D, Moazezi Z, Hajian-Tilaki K. The effects of atorvastatin consumption on biochemical variables in patients with type 2 diabetes mellitus and pre-diabetes. Int J Med Lab. 2022;9(3):198–208.

CAS  Google Scholar 

Almukhtar HM, Faisal IM, Merkhan MM. Acute effect of atorvastatin in comparison with rosuvastatin on glucose homeostasis in hypercholesteremic patients. Pharmacology. 2021;25:25–34.

CAS  Google Scholar 

Werida R, Khairat I, Khedr NF. Effect of atorvastatin versus rosuvastatin on inflammatory biomarkers and LV function in type 2 diabetic patients with dyslipidemia. Biomed Pharmacother. 2021;135:111179.

Article  CAS  PubMed  Google Scholar 

Kosmidou MS, Hatzitolios AI, Adamidou A, Giannopoulos S, Raikos N, Parharidis G, et al. Effects of atorvastatin on red-blood cell Na+/Li+ countertransport in hyperlipidemic patients with and without hypertension. Am J Hypertens. 2008;21(3):303–9.

Article  CAS  PubMed  Google Scholar 

Koh KK, Quon MJ, Han SH, Lee Y, Kim SJ, Shin EK. Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. J Am Coll Cardiol. 2010;55(12):1209–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gumprecht J, Gosho M, Budinski D, Hounslow N. Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20–40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. Diabetes Obes Metab. 2011;13(11):1047–55.

Article  CAS  PubMed  Google Scholar 

Zhang C, Wu X, Shi P, Ma H, Fang F, Feng Q, et al. Diterpenoids inhibit ox-LDL-induced foam cell formation in RAW264. 7 cells by promoting ABCA1 mediated cholesterol efflux. Front Pharmacol. 2023;14:1066758.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lv Y, Yang J, Gao A, Sun S, Zheng X, Chen X, et al. Sortilin promotes macrophage cholesterol accumulation and aortic atherosclerosis through lysosomal degradation of ATP-binding cassette transporter A1 protein. Acta Biochim Biophys Sin. 2019;51(5):471–83.

Article  CAS  PubMed  Google Scholar